講演情報

[WS22-04-P]IFN-γ Modulation of Type 2 Immune Response enhances T cell Anti-tumor Immunity

^○Tzu-Hsuan Chang^1,2, Francesca Alfei³, Stefania Vilbois^1,2, Yingxi Xu^1,2,4,5, Ping-Chih Ho^1,2 (1.Department of Fundamental Oncology, University of Lausanne, Lausanne, Switzerland., 2.Ludwig Institute for Cancer Research, University of Lausanne, Epalinges, Lausanne, Switzerland, 3.Amal Therapeutics, Av. de la Roseraie 64, Genève, Switzerland, 4.National Clinical Research Center for Blood Diseases, Institute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Tianjin, China, 5.Tianjin Institutes of Health Science, Tianjin, China)

キーワード：

IFN-g、acquired resistance、CD8+ T cells、IL-4、type 2 immune response

閲覧にはパスワードが必要です

ログイン

または

セッション詳細へ戻る